Non-Current Liabilities
Thermo Fisher Scientific·Balance Sheet Statement·9 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total Carrying Value of Debt | $35.5B | $35.4B | $31.3B | $34.3B | $35.3B | $35.7B | $39.5B | $43.3B |
| Long-term debt | $35.2B | $35.1B | $31.1B | $34.0B | $35.0B | $35.5B | $39.2B | $42.9B |
| Long-Term Debt and Finance Lease Obligations | $30.3B | $31.2B | $29.1B | $31.4B | $33.0B | $31.9B | $35.9B | $40.1B |
| Other non-current liabilities | $4.4B | $4.3B | $4.0B | $4.0B | $4.3B | $4.3B | $4.3B | $4.4B |
| Contract Liabilities, Non-Current | $1.5B | $1.4B | $1.1B | $1.1B | $1.1B | $1.2B | $1.2B | $1.0B |
| Deferred revenue, net of current portion | $1.5B | $1.4B | $1.1B | $1.1B | $1.1B | $1.2B | $1.2B | $1.0B |
| Total liabilities | — | — | — | — | — | — | $522.0M | $767.0M |
| Finance lease liabilities | $207.0M | $200.0M | $202.0M | $200.0M | $196.0M | $196.0M | $213.0M | $213.0M |
| Finance Lease Liabilities (Total) | $207.0M | $200.0M | $202.0M | $200.0M | $196.0M | $196.0M | $213.0M | $213.0M |